An observational study in Intoxication;Alcohol;Acute and Emergencies, sponsored by Centre Hospitalier Arras. Withdrawn at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-01-11.
Sponsored by Centre Hospitalier Arras · Observational
The study was designed to evaluate the APIVIGIE program use at CH d'Arras. The objective of this program is to reduce repeated visits by the same patient to the emergency room for Alcoholism Severe Paroxysmal
In France, between 10% and 30% of emergency room admissions are linked to problematic alcohol consumption. This considerable weight of alcohol-related problems in the current problematic of emergencies is largely unknown and can lead to blockages in emergencies.
For acute intoxication requiring emergency care, 80% of admissions concern people dependent on alcohol. Here again, this crucial clinical notion is largely ignored: when a patient in a state of intoxication arrives in the emergency room, this should not be considered as a banal and one-off event, it is necessary to put in place a care, if necessary, of addiction.
Supported by a call for projects from the Hauts-de-France Regional Health Agency, the Addictions Service of the Arras Hospital is setting up a monitoring system called APIVIGIE.
APIVIGIE program is offered to patients who present to the emergency room for a diagnosis of API after an evaluation by the liaison team of the addiction service. If the patient agrees to be part of the program, he will receive a resource card with the APIVIGIE phone number to contact if necessary.
The link will be maintained with the Addictology Care, Support and Prevention Center (CSAPA) for a period of 6 months, by telephone consultations, or by video-consultations or face-to-face consultations.
76 studies on the registry are indexed under Alcoholic Intoxication; 17 are open to participants now.
Browse Alcoholic Intoxication studies →Centre Hospitalier Arras is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Participant at API-VIGIE program
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
API-VIGIE program adult participant who agreed to participate in the study
Other: Medical Outcomes Study Short Form 36 (SF 36)
Any stay for adults patients in the emergency room of the ARRAS hospital for API during the period covered (from 1 year before to 1 year after the installation of the APIVIGIE program) (main diagnosis or associated with an API (F10.0 according to the ICD-10 classification used by Department of Medical Information)
Other: observationnal study
completion of questionnaire quality of life SF 36 (inclusion, Month 3, Month 6).
data collection
Number of visits to the Emergency Reception Service for Significant Paroxysmal Alcoholics
1 year before implementation of the program and up to 1 year after implementation of the program
Time frame: during 2 years
weekly consumption of alcoholic beverages
Time frame: Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)
weekly consumption of other substances (cannabis, other substances)
Time frame: Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)
Quality of life score, measured by the Medical Outcomes Study Short Form 36 (SF-36) health scale score.
SF 36 giving a score from 0 to 100. More higher score, more better quality of life.
Time frame: Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)
Start is estimated for Feb 2022; primary completion for Feb 2023, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Arras